Cargando…
Outcome of patients with non‐ischaemic cardiogenic shock supported by percutaneous left ventricular assist device
AIMS: Percutaneous left ventricular assist devices (pVADs) are used to haemodynamically stabilize patients with cardiogenic shock (CS) caused by acute myocardial infarction (AMI). One out of every two patients has a non‐ischaemic cause of CS, and these patients differ profoundly from patients with A...
Autores principales: | Haurand, Jean M., Haberkorn, Sandra, Haschemi, Jafer, Oehler, Daniel, Aubin, Hug, Akhyari, Payam, Boeken, Udo, Kelm, Malte, Westenfeld, Ralf, Horn, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497228/ https://www.ncbi.nlm.nih.gov/pubmed/34424614 http://dx.doi.org/10.1002/ehf2.13546 |
Ejemplares similares
-
Percutaneous left ventricular assist support is associated with less pulmonary congestion and lower rate of pneumonia in patients with cardiogenic shock
por: Haberkorn, Sandra, et al.
Publicado: (2020) -
Outcome and Midterm Survival after Heart Transplantation Is Independent from Donor Length of Stay in the Intensive Care Unit
por: Oehler, Daniel, et al.
Publicado: (2022) -
Reply to Thet et al. Comment on “Oehler et al. Outcome and Midterm Survival after Heart Transplantation Is Independent from Donor Length of Stay in the Intensive Care Unit. Life 2022, 12, 1053”
por: Oehler, Daniel, et al.
Publicado: (2023) -
Early Postoperative Neurologic Events Are Associated With Worse Outcome and Fatal Midterm Survival After Adult Heart Transplantation
por: Oehler, Daniel, et al.
Publicado: (2023) -
Donor Noradrenaline Support Is Not Associated with Decreased Survival in Heart Transplant Recipients
por: Oehler, Daniel, et al.
Publicado: (2022)